Technical Analysis for OCC - Orthocell Ltd
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.82% | |
| Stochastic Reached Oversold | Weakness | 0.82% | |
| Strong but Oversold | Other | 0.82% | |
| Oversold Stochastic | Weakness | 0.82% | |
| 20 DMA Resistance | Bearish | -1.60% | |
| NR7 | Range Contraction | -3.15% |
| Alert | Time |
|---|---|
| Up 2% | 1 day ago |
| Up 1% | 1 day ago |
| Down 1% | 2 days ago |
| Possible Inside Day | 2 days ago |
| Down 3% | 3 days ago |
Get a Trading Sidekick!
Orthocell Ltd Description
Orthocell Limited is a regenerative medicine company. The Company is engaged in the development and commercialization of cell therapies and related technologies. The Company's products include CelGro, a collagen medical device for soft tissue repair in use as an augment to rotator cuff repair, guided bone regeneration and repair of articular cartilage, and Autologous Tenocyte Implantation (Ortho-ATI) for chronic, treatment resistant tendon regeneration. CelGro is targeted on a range of orthopedic, reconstructive and surgical applications. Ortho-ATI is a treatment that uses a minimally invasive, non-surgical approach that uses each patient's own tendon derived stem cells to stimulate tendon regeneration and is delivered through ultrasound guided injection under local anesthetic. The Company's Autologous Chondrocyte Implantation (Ortho-ACI) offers treatment for symptomatic defects of the articulating cartilage of the joints, including the knee and ankle.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Medical Device Sound Surgery Implant Ultrasound Regenerative Medicine Regenerative Stem Cell Stem Cells Plantation Collagen Osteochondritis Dissecans Soft Tissue Repair
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.765 |
| 52 Week Low | 0.35 |
| Average Volume | 749,264 |
| 200-Day Moving Average | 0.432 |
| 50-Day Moving Average | 0.576 |
| 20-Day Moving Average | 0.633 |
| 10-Day Moving Average | 0.639 |
| Average True Range | 0.032 |
| RSI (14) | 48.98 |
| ADX | 26.75 |
| +DI | 21.891 |
| -DI | 20.547 |
| Chandelier Exit (Long, 3 ATRs) | 0.619 |
| Chandelier Exit (Short, 3 ATRs) | 0.706 |
| Upper Bollinger Bands | 0.670 |
| Lower Bollinger Band | 0.595 |
| Percent B (%b) | 0.27 |
| BandWidth | 11.921 |
| MACD Line | 0.009 |
| MACD Signal Line | 0.018 |
| MACD Histogram | -0.0092 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.638 | ||||
| Resistance 3 (R3) | 0.638 | 0.632 | 0.634 | ||
| Resistance 2 (R2) | 0.632 | 0.626 | 0.631 | 0.632 | |
| Resistance 1 (R1) | 0.623 | 0.622 | 0.623 | 0.623 | 0.631 |
| Pivot Point | 0.617 | 0.617 | 0.616 | 0.616 | 0.617 |
| Support 1 (S1) | 0.608 | 0.611 | 0.608 | 0.608 | 0.599 |
| Support 2 (S2) | 0.602 | 0.607 | 0.601 | 0.598 | |
| Support 3 (S3) | 0.593 | 0.602 | 0.596 | ||
| Support 4 (S4) | 0.593 |
